Skip to content

Tyra Biosciences, Inc. TYRA Book value per share

Book value per share at other companies

Incyte logo
IncyteINCY
$27.19+46.9%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$31.43+6.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$11.70-34.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$7.19+20.3%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0.47-81.1%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.43-22.1%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.79B+318%
Enterprise value$1.71B+397%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Calculated from Tyra Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s book value per share?
Tyra Biosciences, Inc. (TYRA) reported book value per share of $6.28 in Q1 2026.
How has Tyra Biosciences, Inc.'s book value per share changed year-over-year?
Tyra Biosciences, Inc.'s book value per share increased by 15.1% year-over-year, from $5.45 to $6.28.
What is the long-term trend for Tyra Biosciences, Inc.'s book value per share?
Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s book value per share has grown at a -13.2% compound annual growth rate (CAGR), from -$8.84 to $4.35.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.